| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.13 | 0.003 |